本页面由Tiger Trade Technology Pte. Ltd.提供服务

Solid Biosciences

8.39
+0.07000.84%
盘后8.23-0.1600-1.91%18:12 EDT
成交量:67.27万
成交额:559.05万
市值:8.26亿
市盈率:-4.21
高:8.43
开:8.26
低:8.06
收:8.32
52周最高:8.87
52周最低:2.41
股本:9,839.13万
流通股本:5,854.24万
量比:0.56
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-1.9922
每股收益(LYR):-3.0550
净资产收益率:-109.90%
总资产收益率:-53.18%
市净率:4.59
市盈率(LYR):-2.75

数据加载中...

2024/06/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/15

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]